Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA BIOCON AJANTA PHARMA/
BIOCON
 
P/E (TTM) x 23.8 36.9 64.6% View Chart
P/BV x 4.9 4.1 118.9% View Chart
Dividend Yield % 0.8 0.2 430.0%  

Financials

 AJANTA PHARMA   BIOCON
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
BIOCON
Mar-22
AJANTA PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,614424 380.6%   
Low Rs1,089315 345.7%   
Sales per share (Unadj.) Rs391.168.2 573.8%  
Earnings per share (Unadj.) Rs83.48.2 1,023.7%  
Cash flow per share (Unadj.) Rs98.114.9 657.0%  
Dividends per share (Unadj.) Rs9.500.50 1,900.0%  
Avg Dividend yield %0.70.1 519.5%  
Book value per share (Unadj.) Rs382.168.5 557.5%  
Shares outstanding (eoy) m85.421,200.60 7.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.55.4 63.7%   
Avg P/E ratio x16.245.3 35.7%  
P/CF ratio (eoy) x13.824.7 55.7%  
Price / Book Value ratio x3.55.4 65.6%  
Dividend payout %11.46.1 185.6%   
Avg Mkt Cap Rs m115,433443,622 26.0%   
No. of employees `000NANA-   
Total wages/salary Rs m6,45818,801 34.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,41081,840 40.8%  
Other income Rs m1,1576,891 16.8%   
Total revenues Rs m34,56788,731 39.0%   
Gross profit Rs m9,29313,827 67.2%  
Depreciation Rs m1,2538,142 15.4%   
Interest Rs m102676 15.1%   
Profit before tax Rs m9,09511,900 76.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9682,115 93.0%   
Profit after tax Rs m7,1279,785 72.8%  
Gross profit margin %27.816.9 164.6%  
Effective tax rate %21.617.8 121.7%   
Net profit margin %21.312.0 178.4%  
BALANCE SHEET DATA
Current assets Rs m24,54883,823 29.3%   
Current liabilities Rs m8,37738,280 21.9%   
Net working cap to sales %48.455.6 87.0%  
Current ratio x2.92.2 133.8%  
Inventory Days Days42101 41.6%  
Debtors Days Days1192 12.1%  
Net fixed assets Rs m19,259117,184 16.4%   
Share capital Rs m1726,003 2.9%   
"Free" reserves Rs m32,46976,281 42.6%   
Net worth Rs m32,64082,284 39.7%   
Long term debt Rs m1639,985 0.0%   
Total assets Rs m43,807201,007 21.8%  
Interest coverage x90.218.6 484.7%   
Debt to equity ratio x00.5 0.1%  
Sales to assets ratio x0.80.4 187.3%   
Return on assets %16.55.2 317.1%  
Return on equity %21.811.9 183.6%  
Return on capital %28.210.3 273.8%  
Exports to sales %00-   
Imports to sales %07.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA6,360 0.0%   
Fx inflow Rs m18,6788,885 210.2%   
Fx outflow Rs m3,6626,360 57.6%   
Net fx Rs m15,0162,525 594.7%   
CASH FLOW
From Operations Rs m5,62011,766 47.8%  
From Investments Rs m-741-16,991 4.4%  
From Financial Activity Rs m-4,6002,421 -190.0%  
Net Cashflow Rs m279-2,433 -11.5%  

Share Holding

Indian Promoters % 70.5 39.7 177.7%  
Foreign collaborators % 0.0 21.0 -  
Indian inst/Mut Fund % 21.4 23.6 90.7%  
FIIs % 8.2 15.8 52.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 39.4 75.0%  
Shareholders   62,048 369,816 16.8%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on AJANTA PHARMA vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Biocon Share Price Performance

Period AJANTA PHARMA Biocon S&P BSE HEALTHCARE
1-Day 1.22% -0.63% -0.10%
1-Month -6.90% 5.56% -1.99%
1-Year -11.30% -22.75% -5.62%
3-Year CAGR 23.81% -0.26% 20.96%
5-Year CAGR 7.06% -11.19% 11.47%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Biocon paid Rs 0.5, and its dividend payout ratio stood at 6.1%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.